Differential Reponses of Hematopoietic Stem and Progenitor Cells to mTOR Inhibition

Abnormal activation of the mammalian target of rapamycin (mTOR) signaling pathway has been observed in a variety of human cancers. Therefore, targeting of the mTOR pathway is an attractive strategy for cancer treatment and several mTOR inhibitors, including AZD8055 (AZD), a novel dual mTORC1/2 inhib...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cells Int
Autors principals: Yang, Aimin, Xiao, Xia, Zhao, Mingfeng, LaRue, Amanda C., Schulte, Bradley A., Wang, Gavin Y.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4499403/
https://ncbi.nlm.nih.gov/pubmed/26221145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/561404
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars